Publications

Effects of ovarian ablation or suppression on breast cancer recurrence and survival: patient-level meta-analysis of 15 000 women in 23 randomised trials

Bradley R. et al, (2026), Lancet, 407, 1699 - 1711

Causes of excess non-lymphoma death in 58,000 patients with DLBCL diagnosed during 1997-2020 and followed for up to 25 years.

Challenger A. et al, (2026), Blood Adv

Histological types of invasive breast cancer in 830,000 women diagnosed in England during 1988–2016

Probert J. et al, (2025), Journal of Pathology Clinical Research, 11

Second cancers in 475 000 women with early invasive breast cancer diagnosed in England during 1993-2016: population based observational cohort study.

McGale P. et al, (2025), BMJ, 390

Radiotherapy to regional nodes in early breast cancer: an individual patient data meta-analysis of 14 324 women in 16 trials.

Early Breast Cancer Trialists' Collaborative Group (EBCTCG) ., (2023), Lancet, 402, 1991 - 2003

Authors' reply to Oke and Welch.

Darby SC. et al, (2023), BMJ, 382

Ki67 and breast cancer mortality in women with invasive breast cancer.

Probert J. et al, (2023), JNCI Cancer Spectr, 7

Breast cancer mortality in 500 000 women with early invasive breast cancer diagnosed in England, 1993-2015: population based observational cohort study.

Taylor C. et al, (2023), BMJ, 381

Anthracycline-containing and taxane-containing chemotherapy for early-stage operable breast cancer: a patient-level meta-analysis of 100 000 women from 86 randomised trials.

Early Breast Cancer Trialists’ Collaborative Group (EBCTCG). Electronic address: bc.overview@ctsu.ox.ac.uk . and Early Breast Cancer Trialists’ Collaborative Group (EBCTCG) ., (2023), Lancet, 401, 1277 - 1292

In Response to Morgan et al. and Li et al.

Goldberg M. et al, (2023), Int J Radiat Oncol Biol Phys, 115, 1012 - 1013

A Meta-Analysis of Trials of Partial Breast Irradiation.

Goldberg M. et al, (2023), Int J Radiat Oncol Biol Phys, 115, 60 - 72

Adjuvant and neoadjuvant breast cancer treatments: A systematic review of their effects on mortality.

Kerr AJ. et al, (2022), Cancer Treat Rev, 105

Aromatase inhibitors versus tamoxifen in premenopausal women with oestrogen receptor-positive early-stage breast cancer treated with ovarian suppression: a patient-level meta-analysis of 7030 women from four randomised trials.

Early Breast Cancer Trialists' Collaborative Group (EBCTCG) ., (2022), Lancet Oncol, 23, 382 - 392

Breast Cancer Diagnostics, Therapy, and Outcomes in Sub-Saharan Africa: A Population-Based Registry Study.

Joko-Fru WY. et al, (2021), J Natl Compr Canc Netw, 20

Trastuzumab for early-stage, HER2-positive breast cancer: a meta-analysis of 13 864 women in seven randomised trials.

Early Breast Cancer Trialists’ Collaborative group (EBCTCG) ., (2021), Lancet Oncol, 22, 1139 - 1150

Search results (90)